Latest Regulatory News

JPMorgan Asset Management has released estimated tax attribution components for its Climate Change Solutions Active ETF for the fiscal year ending June 2025, confirming its status as a Managed Investment Trust.

Vanguard Investments Australia Limited will forgo half-yearly financial reports for select ETFs in their first short financial year, leveraging ASIC’s regulatory relief to streamline reporting.

Zeus Resources has completed the acquisition of the Casablanca Antimony Project in Morocco, unlocking access to exceptionally high-grade antimony mineralisation and positioning itself in a mining-friendly jurisdiction.

Manuka Resources has voluntarily suspended its shares on the ASX pending a significant capital raising announcement, signaling a pivotal moment for the gold miner.

Omni Bridgeway confirms the US Budget Bill signed on 4 July 2025 excludes the proposed Legal Finance tax, a move welcomed by the company amid broad political support.

Chariot Corporation Limited has voluntarily suspended trading of its shares pending a significant acquisition announcement, signaling a pivotal moment for the mineral exploration company.

ECS Botanics is supplying its Avani THC10 capsules to a University of Western Australia clinical trial exploring medicinal cannabis as a treatment for obstructive sleep apnoea. The study aims to shed light on THC’s impact on sleep quality and cognitive function.

BMG Resources has signed a key Memorandum of Understanding to process ore from its Abercromby Gold Project at the nearby Matilda Processing Plant, marking a pivotal step toward production. This agreement supports BMG’s transition from developer to gold producer amid a strong gold price environment.

Marmota Limited has initiated its first-ever drilling campaign at the Greenewood gold discovery, aiming to significantly expand its Gawler Gold project footprint. The program plans 127 reverse circulation holes, potentially reshaping the company’s resource outlook near its flagship Aurora Tank deposit.

Winsome Resources has received crucial Environmental and Social Impact Assessment guidelines from Québec authorities, marking a significant regulatory milestone for its Adina Lithium Project. This development sets the stage for detailed environmental studies and stakeholder engagement ahead of the project's next phase.

EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.

MIXI Australia has secured crucial gaming approvals from Ontario regulators, removing a major obstacle in its proposed takeover of PointsBet Holdings. The bid now awaits shareholder acceptance to proceed.